The U.S. Department of Health and Human Services (HHS) on Thursday released a commissioned report alleging that hospitals and clinics used questionable insurance billing practices in connection with sex-altering procedures for minors, prompting the Trump administration to refer identified providers to federal investigators.
The 64-page report, “Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of ‘Gender Medicine,’” examines insurance claims, medical coding, financial incentives, hospital records, whistleblower testimony, federal investigations, and interviews with patients and parents. HHS said the report identified approximately $50 million in insurance claims for “puberty blockers” billed under an unspecified endocrine-disorder code between 2015 and 2025.
A brief documentary showcasing the report’s conclusions and featuring the experiences of individuals affected by exploitative gender medical practices was also launched alongside the report:
What HHS Is Alleging
The report focuses heavily on the use of medical billing codes that, according to its authors, could obscure the actual reason a treatment was provided.
HHS said the nationwide claims analysis identified about $50 million in claims for “puberty blockers” involving patients ages 9 to 17 that used the E34.9 diagnosis code, “Endocrine Disorder, Unspecified,” without a gender-related diagnosis or a diagnosis for precocious puberty on the same claim. The report separately identified nearly $11 million in claims involving patients ages 13 to 17 that used the E30.1 code for precocious puberty.
Importantly, the report itself describes these findings as potential fraud and anomalous billing patterns requiring further investigation, rather than judicial findings that every provider identified committed fraud.
The report’s appendix states that organizations listed in its claims cohorts had at least one qualifying claim, but that the roster does not indicate the volume of claims attributable to each organization. It also cautions that patient ages were estimated from birth years and should therefore be considered approximate.
More Than 225 Pediatric Programs Identified
According to HHS, more than 225 hospitals and health systems established pediatric “gender” programs nationwide during the period examined.
The report argues that these programs created continuing sources of revenue for pediatric, endocrinology, and surgical services. It describes what it calls a “captive patient” model in which children receiving these treatments could require continuing medical appointments, laboratory monitoring, medications, and potentially additional procedures.
The report’s conclusions go beyond billing practices. Its authors contend that financial incentives, professional organizations, political pressure, and inadequate government oversight contributed to the expansion of pediatric sex-altering procedures.
Those assertions are the findings and conclusions of the commissioned report, rather than established findings against every hospital or physician named in its appendices.
Who Is Actually Being Investigated?
HHS Secretary Robert F. Kennedy Jr. and Vice President JD Vance, acting in his capacity as chairman of the White House Task Force to Eliminate Fraud, referred providers identified in the report to federal authorities for possible violations of law.
HHS said Vance made referrals to the Department of Justice, while Kennedy referred providers to the HHS Office of Inspector General (OIG).
For years now, some hospitals and healthcare providers have been subjecting children to horrific, experimental treatments in service of radical gender ideologies. Today, thanks to the Wolves in White Coats report released by @HHSGov, we know why: profit. It turns out that… pic.twitter.com/B7K7iumpYC
— JD Vance (@JDVance) August 13, 2026
A referral, however, is not an indictment, criminal charge, conviction, or finding of liability.
The HHS referral letter, dated August 12, specifically says the providers are being referred for investigation into “possible violation of federal statutes.” It says the claims analysis identified an objectively defined group of claims with “potentially anomalous billing patterns” that warranted additional scrutiny.
The letter lists numerous organizations, including Boston Children’s Hospital, Children’s Hospital Colorado, Children’s Hospital Los Angeles, Children’s Hospital of Philadelphia, Children’s Medical Center, Vanderbilt University Medical Center, Seattle Children’s Hospital, Rady Children’s Hospital San Diego, Texas Tech University Health Sciences, and others.
The list should not be interpreted as a list of organizations already found to have committed fraud.
Texas Providers Appear on the Referral Lists
The federal referral has particular relevance to Texas.
Among the organizations appearing in the documents are Children’s Medical Center, Texas Tech University Health Sciences, Texas Tech University Health Sciences Center Amarillo, Cook Children’s, and other Texas-connected providers. The referral documents also identify Planned Parenthood of Greater Texas in a separate cohort involving claims for cross-sex hormones and patients age 17 or younger in states where HHS says restrictions were in effect.
The report also references an earlier Texas development involving Texas Children’s Hospital. According to the HHS report, an investigation by the Texas attorney general culminated in a $10 million healthcare fraud settlement with the hospital in May 2026.
That prior settlement is separate from Thursday’s federal referrals.
Is Anyone Actually Being Held Accountable?
Not yet in the criminal sense.
The Trump administration has taken an enforcement step by sending the identified providers to federal investigative authorities. But the referrals begin, rather than conclude, an accountability process.
The Department of Justice could investigate whether particular providers violated federal law. HHS OIG can independently examine the claims and supporting records. Depending on what investigators find, possible consequences could include additional administrative action, repayment demands, civil enforcement, or criminal prosecution. None of those outcomes should be assumed before investigators complete their work.
HHS itself described Thursday’s referrals as being for “possible violations of federal law.”
That distinction matters because a suspicious billing pattern is not necessarily proof that a provider knowingly submitted a fraudulent claim.
What Happens Next?
HHS said the report recommends stronger review of insurance coding and billing, increased oversight of claims submitted to government health programs, and referral of suspicious billing activity for investigation when warranted.
Kennedy said the administration intends to pursue the evidence identified in the report.
“Doctors and hospitals must put children’s health ahead of ideology and financial gain. This report identifies troubling billing practices that demand scrutiny. HHS will follow the evidence, protect taxpayers, and hold accountable anyone who broke the law or violated the trust of patients and families. Under President Trump’s leadership, we are restoring transparency and integrity to American medicine.”
CMS Administrator Dr. Mehmet Oz said the agency would examine billing practices that obscure the care provided.
“CMS has a duty to ensure taxpayer dollars are spent lawfully and honestly.”
The immediate question is therefore no longer simply whether the allegations contained in “Wolves in White Coats” are politically controversial. The next question is whether federal investigators can substantiate individual cases of improper billing or other violations and, if so, what enforcement actions follow.
For now, the administration has made referrals and initiated a pathway for investigation. It has not announced convictions or final findings of fraud against the providers named in the report.
Provided by Dallas Express
